| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.092 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |